用主题建模阐明癌症的神经发育轨迹:揭示脑髓母细胞瘤中持久的外部颗粒层血统
Ashmitha Rajendran1,2, Parthiv Haldipur3, Sonali Arora4
1Department of Biomedical Informatics and Medical Education, University of Washington School of Medicine, Seattle, WA.
bioRxiv : the preprint server for biology
|November 26, 2025
概括
研究人员确定了胎儿小脑的不同发育阶段,揭示了这些过程是如何反映在儿科Sonic hedgehog medulloblastoma中. 这个框架有助于理解大脑发育和癌症.
科学领域:
- 神经科学是一个神经科学.
- 发展生物学 发展生物学
- 在瘤学瘤学.
背景情况:
- 大脑小脑唇对于产生神经元至关重要,它构成了成年大脑神经元人口的一半以上.
- 标准的聚类方法难以识别过渡性唇前代细胞,阻碍了对小脑发育和脑髓母细胞瘤起源的理解.
- 脑髓母细胞瘤是一种常见的儿科脑瘤,其存活率各不相同,Sonic hedgehog (SHH) 亚型的存活率特别差.
研究的目的:
- 在小脑发育过程中识别和表征罗姆巴唇和外部颗粒层 (EGL) 的原始状态.
- 调查这些发育特征在SHH髓母细胞瘤中的持久性.
- 开发一个可转移的框架,在不同的数据集中比较发育和疾病状态.
主要方法:
- 应用了一个新的主题建模框架来分析超过一百万个胎儿小脑核.
- 在罗姆巴唇和EGL.内识别出不同的增殖和分化细胞状态.
- 在SHH髓母细胞瘤样本中验证了发育特征.
主要成果:
- 识别出多发性罗姆巴唇和EGL状态,分为质和神经元谱系.
- 捕获了从外部EGL (oEGL) 增殖到内部EGL (iEGL) 差异化的发展谱.
- 证明在SHH髓母细胞瘤中存在发育特征,证实了颗粒神经元前体 (GNP) 的起源,并揭示了特定年龄的分子程序.
结论:
- 开发的主题建模框架成功地识别了小脑中短暂的祖先种群和发育轨迹.
- 这些发育特征在SHH髓母细胞瘤中保存,为瘤起源和异质性提供了洞察力.
- 该框架提供了一个可转移的解决方案,用于比较跨技术的发展和疾病的基因组图谱.
相关概念视频
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K


